Search research articles
Contact Us
Filters
Showing results (11-20 of 82) with videos related to
Page
of 9
Sort By:
Biomarkers in Medicine
|
April 10, 2020
Basic knowledge on BCR-ABL1-positive extracellular vesicles
Ancuta Jurj, Sergiu Pasca, Patric Teodorescu, et al.
Seminars in Cancer Biology
|
December 13, 2021
Focus on organoids: cooperation and interconnection with extracellular vesicles - Is this the future of in vitro modeling?
Ancuta Jurj, Sergiu Pasca, Cornelia Braicu, et al.
Biomedicines
|
November 27, 2021
Characteristics of Dental Resin-Based Composites in Leukemia Saliva: An In Vitro Analysis
Alexandru Mester, Marioara Moldovan, Stanca Cuc, et al.
Urologia Internationalis
|
January 20, 2020
Mental Fatigue Evaluation of Surgical Teams during a Regular Workday in a High-Volume Tertiary Healthcare Center
Bogdan Petrut, Ioana Berindan-Neagoe, Dragos I Feflea, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 16, 2021
Comparison of peripheral blood stem cell mobilization with filgrastim versus pegfilgrastim in lymphoma patients - single center experience
Lavinia Lipan, Andrei Colita, Laura Stefan, et al.
Journal of Clinical Medicine
|
August 27, 2021
Hepatic Hydrothorax-An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
Daniela Matei, Rares Craciun, Dana Crisan, et al.
Frontiers in Oncology
|
October 15, 2019
Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the <i>Avant-Garde</i> of Molecular Hematology
Vlad Moisoiu, Patric Teodorescu, Lorand Parajdi, et al.
Haematologica
|
July 6, 2023
An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes
Patric Teodorescu, Sergiu Pasca, InYoung Choi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Deleterious mitochondrial heteroplasmy drives high-risk clonal hematopoiesis and hematological malignancy
Dan E Arking, Tryggvi McDonald, Wen Shi, et al.
European Journal of Hospital Pharmacy : Science and Practice
|
February 5, 2021
Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease
Sabina Iluta, Sergiu Pasca, Delia Dima, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 82) with videos related to
Sort By:
Page
of 9
Biomarkers in Medicine
|
April 10, 2020
Basic knowledge on BCR-ABL1-positive extracellular vesicles
Ancuta Jurj, Sergiu Pasca, Patric Teodorescu, et al.
Seminars in Cancer Biology
|
December 13, 2021
Focus on organoids: cooperation and interconnection with extracellular vesicles - Is this the future of in vitro modeling?
Ancuta Jurj, Sergiu Pasca, Cornelia Braicu, et al.
Biomedicines
|
November 27, 2021
Characteristics of Dental Resin-Based Composites in Leukemia Saliva: An In Vitro Analysis
Alexandru Mester, Marioara Moldovan, Stanca Cuc, et al.
Urologia Internationalis
|
January 20, 2020
Mental Fatigue Evaluation of Surgical Teams during a Regular Workday in a High-Volume Tertiary Healthcare Center
Bogdan Petrut, Ioana Berindan-Neagoe, Dragos I Feflea, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 16, 2021
Comparison of peripheral blood stem cell mobilization with filgrastim versus pegfilgrastim in lymphoma patients - single center experience
Lavinia Lipan, Andrei Colita, Laura Stefan, et al.
Journal of Clinical Medicine
|
August 27, 2021
Hepatic Hydrothorax-An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
Daniela Matei, Rares Craciun, Dana Crisan, et al.
Frontiers in Oncology
|
October 15, 2019
Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the <i>Avant-Garde</i> of Molecular Hematology
Vlad Moisoiu, Patric Teodorescu, Lorand Parajdi, et al.
Haematologica
|
July 6, 2023
An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes
Patric Teodorescu, Sergiu Pasca, InYoung Choi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Deleterious mitochondrial heteroplasmy drives high-risk clonal hematopoiesis and hematological malignancy
Dan E Arking, Tryggvi McDonald, Wen Shi, et al.
European Journal of Hospital Pharmacy : Science and Practice
|
February 5, 2021
Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease
Sabina Iluta, Sergiu Pasca, Delia Dima, et al.
Page
of 9